MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Revenue
$23,170
Net Income
-$2,154,405
Net Profit Margin
-9298.25%
EPS
-$0.12
Unit: Dollar
Revenue Breakdown
Product
Royalty
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Revenues
23,170
19,600
11,800
303,300
Cost of goods sold
7,385
1,636
10,570
8,729
Gross profit
15,785
17,964
1,230
294,571
Research and development
1,926,311
3,559,712
2,594,750
2,225,882
General and administrative
1,475,207
283,552
1,115,491
1,373,976
Total operating expenses
3,401,518
3,843,264
3,710,241
3,599,858
Loss from operations
-3,385,733
-3,825,300
-3,709,011
-3,305,287
Interest income, net
-
34,586
57,740
73,915
Dividend and interest income, net
5,479
-
-
-
Other income
5,728
14,112
930
518
Change in fair value of warrant liabilities
1,220,121
568,966
612,064
574,591
Gain on exchange of warrants
-
-
-
0
Total other income (expense)
1,231,328
617,664
670,734
649,024
Net loss
-2,154,405
-3,207,636
-3,038,277
-2,656,263
Basic EPS
-0.12
-0.329
-0.33
-0.3
Diluted EPS
-0.12
-0.329
-0.33
-0.3
Basic Average Shares
17,727,747
9,758,763
9,116,172
8,740,382
Diluted Average Shares
17,727,747
9,758,763
9,116,172
8,740,382
Page 1
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Change in fair value of
warrant liabilities
$1,220,121
(292.41%↑ Y/Y)
Other income
$5,728
(203.39%↑ Y/Y)
Dividend and interest
income, net
$5,479
Product
$11,870
Royalty
$11,300
Net loss
-$2,154,405
(59.65%↑ Y/Y)
Total other income
(expense)
$1,231,328
(331.34%↑ Y/Y)
Revenues
$23,170
(-7.32%↓ Y/Y)
Loss from operations
-$3,385,733
(29.57%↑ Y/Y)
Gross profit
$15,785
(-28.55%↓ Y/Y)
Cost of goods sold
$7,385
(153.87%↑ Y/Y)
Total operating
expenses
$3,401,518
(-29.57%↓ Y/Y)
Research and development
$1,926,311
(12.37%↑ Y/Y)
General and
administrative
$1,475,207
(-52.65%↓ Y/Y)
Buy us a coffee
BioRestorative Therapies, Inc. (BRTX)
BioRestorative Therapies, Inc. (BRTX)